A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia
Clinical trial NCT03201562 · COMPLETED
Trial details
- NCT number
- NCT03201562
- Sponsor
- LENZ Therapeutics, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-30
- Primary completion
- 2018-05-20
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.